166 related articles for article (PubMed ID: 25410736)
1. Direct In Vivo Human Intestinal Permeability (Peff ) Determined with Different Clinical Perfusion and Intubation Methods.
Dahlgren D; Roos C; Sjögren E; Lennernäs H
J Pharm Sci; 2015 Sep; 104(9):2702-26. PubMed ID: 25410736
[TBL] [Abstract][Full Text] [Related]
2. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
3. Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data.
Sjögren E; Dahlgren D; Roos C; Lennernäs H
Mol Pharm; 2015 Jun; 12(6):2026-39. PubMed ID: 25919764
[TBL] [Abstract][Full Text] [Related]
4. Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.
Pade D; Jamei M; Rostami-Hodjegan A; Turner DB
Biopharm Drug Dispos; 2017 Mar; 38(2):94-114. PubMed ID: 28214380
[TBL] [Abstract][Full Text] [Related]
5. Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms.
Dahlgren D; Roos C; Johansson P; Lundqvist A; Tannergren C; Abrahamsson B; Sjögren E; Lennernäs H
Mol Pharm; 2016 Sep; 13(9):3022-33. PubMed ID: 27500599
[TBL] [Abstract][Full Text] [Related]
6. Human intestinal permeability.
Lennernäs H
J Pharm Sci; 1998 Apr; 87(4):403-10. PubMed ID: 9548891
[TBL] [Abstract][Full Text] [Related]
7. Human in vivo regional intestinal permeability: importance for pharmaceutical drug development.
Lennernäs H
Mol Pharm; 2014 Jan; 11(1):12-23. PubMed ID: 24206063
[TBL] [Abstract][Full Text] [Related]
8. Regional Intestinal Permeability in Rats: A Comparison of Methods.
Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
[TBL] [Abstract][Full Text] [Related]
9. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M
J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800
[TBL] [Abstract][Full Text] [Related]
10. Regional Intestinal Permeability of Three Model Drugs in Human.
Dahlgren D; Roos C; Lundqvist A; Abrahamsson B; Tannergren C; Hellström PM; Sjögren E; Lennernäs H
Mol Pharm; 2016 Sep; 13(9):3013-21. PubMed ID: 27504798
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two approaches of intestinal absorption by puerarin.
Li H; Dong L; Liu Y; Wang G; Zhang L; Qiao Y
J Pharmacol Toxicol Methods; 2014; 70(1):6-11. PubMed ID: 24674709
[TBL] [Abstract][Full Text] [Related]
12. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
[TBL] [Abstract][Full Text] [Related]
13. Human jejunal effective permeability and its correlation with preclinical drug absorption models.
Lennernäs H
J Pharm Pharmacol; 1997 Jul; 49(7):627-38. PubMed ID: 9255703
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
Zhang W; Liu H; Liu C
Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470
[TBL] [Abstract][Full Text] [Related]
15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
16. Comparison between permeability coefficients in rat and human jejunum.
Fagerholm U; Johansson M; Lennernäs H
Pharm Res; 1996 Sep; 13(9):1336-42. PubMed ID: 8893271
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
[TBL] [Abstract][Full Text] [Related]
18. Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo.
Lennernäs H
Adv Drug Deliv Rev; 2007 Sep; 59(11):1103-20. PubMed ID: 17900749
[TBL] [Abstract][Full Text] [Related]
19. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
20. [Applicability analysis and evaluation of aglycones in single-pass intestinal perfusion technique based on PBPK model].
Liu Y; Zhang X; Shi XJ; Wen YX; Yang L; Dong L
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3645-3652. PubMed ID: 31602936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
